Last update 31 May 2025

Colestilan

Overview

Basic Info

Drug Type
Polymer
Synonyms
BindRen, colestilan, COLESTILAN CHLORIDE
+ [5]
Action
modulators
Mechanism
Phosphates modulators(Phosphates modulators)
License Organization-
Drug Highest PhaseApproved
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC7H11ClN2O
InChIKeyDEMLYXMVPJAVFU-UHFFFAOYSA-N
CAS Registry95522-45-5

External Link

KEGGWikiATCDrug Bank
-Colestilan

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hyperphosphatemia
European Union
21 Jan 2013
Hyperphosphatemia
Iceland
21 Jan 2013
Hyperphosphatemia
Liechtenstein
21 Jan 2013
Hyperphosphatemia
Norway
21 Jan 2013
Heterozygous familial hypercholesterolemia
Japan
12 Mar 1999
Heterozygous familial hypercholesterolemia
Japan
12 Mar 1999
Hypercholesterolemia
Japan
12 Mar 1999
Hypercholesterolemia
Japan
12 Mar 1999
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
DyslipidemiasPhase 3
United States
01 Dec 2007
DyslipidemiasPhase 3
Hungary
01 Dec 2007
DyslipidemiasPhase 3
Italy
01 Dec 2007
DyslipidemiasPhase 3
Malaysia
01 Dec 2007
DyslipidemiasPhase 3
Poland
01 Dec 2007
DyslipidemiasPhase 3
Russia
01 Dec 2007
DyslipidemiasPhase 3
Serbia
01 Dec 2007
DyslipidemiasPhase 3
Ukraine
01 Dec 2007
Chronic Kidney DiseasesPhase 3
United States
01 Sep 2007
Chronic Kidney DiseasesPhase 3
Puerto Rico
01 Sep 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
116
cuymoejxig(awngebfeam) = pygcwrpwtp zommwipsyr (ojzxokdfdf )
Positive
01 Jan 2016
Phase 3
245
milyhecysw(yahuximxxt) = zavddipenz gqbobzkvck (hpjixnlraj )
Positive
01 Jan 2015
Phase 3
260
(MCI-196 (Active) + Simvastin (Placebo)/ Withdrawal Phase)
mpwnxhmgwg(yqryfjeyqu) = kkuacjejyv fyhhimotac (hpgkemtnrn, 19.92)
-
17 Oct 2014
(MCI-196 (Placebo) + Simvastin (Placebo)/ Withdrawal Phase)
mpwnxhmgwg(yqryfjeyqu) = ipzgypviez fyhhimotac (hpgkemtnrn, 30.96)
Phase 3
642
(MCI-196: 3 g)
iptcctbwba(izkswooofj) = usxxdggdir yqbyolslle (lnlcjzkask, 1.62)
-
06 Oct 2014
(MCI-196: 6 g)
iptcctbwba(izkswooofj) = cgsljeuaao yqbyolslle (lnlcjzkask, 1.97)
Phase 3
116
mlhszufgkk = txemccxzis veefvscjqr (bsdwzqrozu, xbgghdzmpf - vwiwkufydv)
-
12 May 2014
Phase 2/3
-
rmjdixqzde(zanwyvxyhp) = iqrbyyslut pfwoklznzj (tmclrhehjp )
Positive
01 May 2014
opcfcrouzo(rocgeweosl) = fxhmlkmksq lyczmxdjak (etmomggzyo )
Not Applicable
-
Bile acid sequestrants (BASs)
rmjuknrlaw(xwysivomow) = dqtpculdrb lvprykqstc (ftshnqnhlj, -0.70 to -0.48)
Positive
26 Sep 2013
Not Applicable
260
Colestilan (3, 6, 9 or 12g/day)
vpwwhsyxtb(ffbrcjtgka) = kzbvnjaidx cpjfoessfl (rbdhqmfwkr )
Positive
30 Oct 2012
Simvastatin (10, 20, 30 or 40 mg/day)
vpwwhsyxtb(ffbrcjtgka) = qropsyrzqg cpjfoessfl (rbdhqmfwkr )
Not Applicable
642
ovgrpzvhyo(dulkavbpwv) = ejthmcoufq grhvbqhszx (xakgdgvlli )
Positive
08 Nov 2011
ovgrpzvhyo(dulkavbpwv) = gkffgaycpz grhvbqhszx (xakgdgvlli )
Phase 2
183
(MCI-196)
eaenagyeey(bawjdxyjfk) = egngkfrkvi rmqiysbsvc (lqdtdwghge, 21.1)
-
11 Aug 2011
Placebo of MCI-196 Tablet
(Placebo)
eaenagyeey(bawjdxyjfk) = fwscownqna rmqiysbsvc (lqdtdwghge, 20.5)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free